Sanofi (NASDAQ:SNY) Position Increased by Mission Wealth Management LP

Mission Wealth Management LP increased its position in shares of Sanofi (NASDAQ:SNY) by 8.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,748 shares of the company’s stock after acquiring an additional 621 shares during the period. Mission Wealth Management LP’s holdings in Sanofi were worth $374,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Synergy Asset Management LLC purchased a new stake in shares of Sanofi during the fourth quarter worth $25,000. McClarren Financial Advisors Inc. increased its position in Sanofi by 952.6% during the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after buying an additional 543 shares during the last quarter. Sunbelt Securities Inc. increased its position in Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after buying an additional 313 shares during the last quarter. Sierra Ocean LLC acquired a new position in Sanofi during the fourth quarter worth $44,000. Finally, Versant Capital Management Inc acquired a new position in Sanofi during the fourth quarter worth $54,000. 14.04% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have commented on SNY. Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. StockNews.com downgraded shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $60.00.

Sanofi Trading Up 2.5 %

Shares of NASDAQ:SNY opened at $59.15 on Thursday. The company has a market cap of $150.11 billion, a P/E ratio of 23.76, a P/E/G ratio of 1.01 and a beta of 0.57. The stock’s 50-day moving average is $52.22 and its 200-day moving average is $52.68. Sanofi has a 52-week low of $45.22 and a 52-week high of $59.19. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. Equities research analysts predict that Sanofi will post 4.36 earnings per share for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.